Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Chemical Information and Modeling
|
February 11, 2015
Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides
Fergal J Duffy, Darragh O'Donovan, Marc Devocelle, et al.
Plos One
|
January 29, 2019
Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome
Kevin T O'Brien, Kalyan Golla, Tilen Kranjc, et al.
Genes & Development
|
October 24, 2015
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence
Gerard L Brien, Evan Healy, Emilia Jerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2022
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
Theodore W Laetsch, Shannon L Maude, Susana Rives, et al.
Blood
|
January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Chemical Information and Modeling
|
February 11, 2015
Virtual screening using combinatorial cyclic peptide libraries reveals protein interfaces readily targetable by cyclic peptides
Fergal J Duffy, Darragh O'Donovan, Marc Devocelle, et al.
Plos One
|
January 29, 2019
Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome
Kevin T O'Brien, Kalyan Golla, Tilen Kranjc, et al.
Genes & Development
|
October 24, 2015
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescence
Gerard L Brien, Evan Healy, Emilia Jerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2022
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial
Theodore W Laetsch, Shannon L Maude, Susana Rives, et al.
Blood
|
January 9, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, et al.
Page
of 1